GLAXO Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - GlaxoSmithKline Pakistan Ltd

Watchlist Manager

Watchlist

Price: 323.01 PKR -0.02%

Market Cap: Rs102.9B

G	GlaxoSmithKline Pakistan Ltd KAR:GLAXO	PK
	FREYR Battery SA NYSE:FREY	LU
T	Top Energy Company Ltd Shanxi SSE:600780	CN
C	CEVA Inc SWB:PVJA	US
	Provenance Gold Corp OTC:PVGDF	CA
R	Rio2 Ltd OTC:RIOFF	CA
A	Aspermont Ltd ASX:ASP	AU
A	Admiralty Resources NL SWB:AHS	AU
E	Ecoslops SA F:7T0	FR
Q	QDM International Inc OTC:QDMI	CN
	Iren SpA F:TZ8	IT
	Prospector Metals Corp OTC:PMCOF	CA
A	Allot Ltd F:AG6	IL
	Mapfre SA MAD:MAP	ES
E	EnerSpar Corp XTSX:ENER	CA
	Faron Pharmaceuticals Oy F:4FR	FI
D	DevEx Resources Ltd OTC:UREQF	AU
A	Accelleron Industries AG OTC:ACLIF	CH
P	Premier American Uranium Inc OTC:PAUIF	CA

Profitability Summary

GlaxoSmithKline Pakistan Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

38%

Sustainable 3Y Average Gross Margin

23%

Gross Margin is Increasing

11% > 38%

Healthy Operating Margin

25%

Sustainable 3Y Average Operating Margin

15%

Operating Margin is Increasing

7% > 25%

Healthy Net Margin

16%

Low 3Y Average Net Margin

Net Margin is Increasing

3% > 16%

Exceptional Free Cash Flow Margin

12%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-12% > 12%

Exceptional ROE

32%

Positive 3Y Average ROE

Positive 3Y Average ROIC

18%

ROIC is Increasing

5% > 32%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.